These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
531 related articles for article (PubMed ID: 29207091)
1. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways. Cao F; Wang S; Wang H; Tang W Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091 [TBL] [Abstract][Full Text] [Related]
2. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model. Ding C; Li L; Yang T; Fan X; Wu G BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020 [TBL] [Abstract][Full Text] [Related]
3. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels. Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer. Wang L; Yang D; Tian J; Gao A; Shen Y; Ren X; Li X; Jiang G; Dong T Oncotarget; 2017 Apr; 8(16):26323-26333. PubMed ID: 28412748 [TBL] [Abstract][Full Text] [Related]
5. Arginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathway. Yang L; Xiao M; Li X; Tang Y; Wang YL Int J Mol Med; 2016 Mar; 37(3):734-42. PubMed ID: 26847718 [TBL] [Abstract][Full Text] [Related]
6. CCR6 promotes tumor angiogenesis via the AKT/NF-κB/VEGF pathway in colorectal cancer. Zhu CC; Chen C; Xu ZQ; Zhao JK; Ou BC; Sun J; Zheng MH; Zong YP; Lu AG Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):387-397. PubMed ID: 29097259 [TBL] [Abstract][Full Text] [Related]
7. Fibroblast activation protein in osteosarcoma cells promotes angiogenesis via AKT and ERK signaling pathways. Zeng C; Wen M; Liu X Oncol Lett; 2018 Apr; 15(4):6029-6035. PubMed ID: 29552230 [TBL] [Abstract][Full Text] [Related]
8. Predictive values of FAP and HGF for tumor angiogenesis and metastasis in colorectal cancer. Ma TH; Gao CC; Xie R; Yang XZ; Dai WJ; Zhang JL; Yan W; Wu SN Neoplasma; 2017; 64(6):880-886. PubMed ID: 28895412 [TBL] [Abstract][Full Text] [Related]
9. TIPE regulates VEGFR2 expression and promotes angiogenesis in colorectal cancer. Zhong M; Li N; Qiu X; Ye Y; Chen H; Hua J; Yin P; Zhuang G Int J Biol Sci; 2020; 16(2):272-283. PubMed ID: 31929755 [No Abstract] [Full Text] [Related]
10. Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling. Sun Y; Wu C; Ma J; Yang Y; Man X; Wu H; Li S Exp Cell Res; 2016 Oct; 347(2):274-82. PubMed ID: 27426724 [TBL] [Abstract][Full Text] [Related]
11. Chemokine receptor 7 targets the vascular endothelial growth factor via the AKT/ERK pathway to regulate angiogenesis in colon cancer. Li X; Wang X; Li Z; Zhang Z; Zhang Y Cancer Med; 2019 Sep; 8(11):5327-5340. PubMed ID: 31348616 [TBL] [Abstract][Full Text] [Related]
12. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer. Chen C; Xu ZQ; Zong YP; Ou BC; Shen XH; Feng H; Zheng MH; Zhao JK; Lu AG Cell Death Dis; 2019 Feb; 10(3):178. PubMed ID: 30792394 [TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling. Huang SW; Lien JC; Kuo SC; Huang TF Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611 [TBL] [Abstract][Full Text] [Related]
14. TMEM206 promotes the malignancy of colorectal cancer cells by interacting with AKT and extracellular signal-regulated kinase signaling pathways. Zhao J; Zhu D; Zhang X; Zhang Y; Zhou J; Dong M J Cell Physiol; 2019 Jul; 234(7):10888-10898. PubMed ID: 30417481 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option. Dienus K; Bayat A; Gilmore BF; Seifert O Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of inhibition of the abnormal proliferation of human umbilical vein endothelial cells by hydroxysafflor-yellow A. Wang J; Wang J; Wang X; Liu L; Hu J; Yu X; Xu Y; Niu X; Lin Z; Zhang Y; Zhang X; Zhang Q Pharm Biol; 2016 Sep; 54(9):1800-7. PubMed ID: 26730646 [TBL] [Abstract][Full Text] [Related]
17. Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells. Lai D; Ma L; Wang F Int J Oncol; 2012 Aug; 41(2):541-50. PubMed ID: 22614695 [TBL] [Abstract][Full Text] [Related]
18. 4'-hydroxywogonin inhibits colorectal cancer angiogenesis by disrupting PI3K/AKT signaling. Sun D; Zhang F; Qian J; Shen W; Fan H; Tan J; Li L; Xu C; Yang Y; Cheng H Chem Biol Interact; 2018 Dec; 296():26-33. PubMed ID: 30217479 [TBL] [Abstract][Full Text] [Related]
19. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer. Ye Q; Cai W; Zheng Y; Evers BM; She QB Oncogene; 2014 Apr; 33(14):1828-39. PubMed ID: 23624914 [TBL] [Abstract][Full Text] [Related]
20. CCL19 suppresses angiogenesis through promoting miR-206 and inhibiting Met/ERK/Elk-1/HIF-1α/VEGF-A pathway in colorectal cancer. Xu Z; Zhu C; Chen C; Zong Y; Feng H; Liu D; Feng W; Zhao J; Lu A Cell Death Dis; 2018 Sep; 9(10):974. PubMed ID: 30250188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]